Article
Biochemical and clinical pharmacology of 5-fluorouracil.
Oncology (Williston Park, N.Y.) - 1 Oct 1998
Schilsky R L
Abstract excerpt
The cellular and clinical pharmacology of fluoropyrimidines is characterized by marked interpatient variability in tumor response and patient tolerance. Understanding the metabolic pathways followed by 5-fluorouracil (5-FU) has led to new strategies to optimize therapy with these important agents...
Topics
- Administration, Oral
- Antimetabolites, Antineoplastic
- Biological Availability
- DNA, Neoplasm
- Dihydrouracil Dehydrogenase (NADP)
- Fluorouracil
- Humans
- Neoplasms
- Oxidoreductases
- Phenotype
